Aug 11 (Reuters) - Aethlon Medical Inc:
* Agreement with defense advanced research projects agency to validate in vitro capture of middle east respiratory syndrome coronavirus
* Its researchers have completed in vitro studies that demonstrate “rapid capture” of zika virus by Aethlon hemopurifier
* The zika studies demonstrated a 95% clearance of zika virus from cell culture fluid in 5.5 hours
* Zika studies demonstrated an approximate 50% clearance of zika from human blood serum in 5 hours Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.